S. AKSU Et Al. , "Idelalisib at the Crossroads of B-Cell Lymphoproliferative Disorders," UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.26, no.1, pp.12-19, 2016
AKSU, S. Et Al. 2016. Idelalisib at the Crossroads of B-Cell Lymphoproliferative Disorders. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.26, no.1 , 12-19.
AKSU, S., Ayyildiz, O., ETGÜL, S., GÖKER, H., GÜNEŞ, G., HAZNEDAROĞLU, İ. C., ... İLHAN, O.(2016). Idelalisib at the Crossroads of B-Cell Lymphoproliferative Disorders. UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.26, no.1, 12-19.
AKSU, SALİH Et Al. "Idelalisib at the Crossroads of B-Cell Lymphoproliferative Disorders," UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.26, no.1, 12-19, 2016
AKSU, SALİH Et Al. "Idelalisib at the Crossroads of B-Cell Lymphoproliferative Disorders." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.26, no.1, pp.12-19, 2016
AKSU, S. Et Al. (2016) . "Idelalisib at the Crossroads of B-Cell Lymphoproliferative Disorders." UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI , vol.26, no.1, pp.12-19.
@article{article, author={SALİH AKSU Et Al. }, title={Idelalisib at the Crossroads of B-Cell Lymphoproliferative Disorders}, journal={UHOD-ULUSLARARASI HEMATOLOJI-ONKOLOJI DERGISI}, year=2016, pages={12-19} }